However, a preventive anti-IL-17 antibody treatment significantly inhibited the clinical and histological symptoms of arthritis in wild-type mice (with a total of 16 mice in each group, an incidence was reached of 54% and 13% respectively in control-treated and anti-IL-17-treated wild-type mice). Here, IL17A is linked to arthritic joint disease.